Article citationsMore >>

Woodruff MC, Ramonell RP, Lee F E-H, Sanz I. Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection. medRxiv. Preprint. 2020 Oct 23.

has been cited by the following article:

Article

The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?

1Chaim Sheba Medical Center, the Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel


International Journal of Celiac Disease. 2021, Vol. 9 No. 1, 6-9
DOI: 10.12691/ijcd-9-1-8
Copyright © 2021 Science and Education Publishing

Cite this paper:
Aaron Lerner. The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?. International Journal of Celiac Disease. 2021; 9(1):6-9. doi: 10.12691/ijcd-9-1-8.

Correspondence to: Aaron  Lerner, Chaim Sheba Medical Center, the Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel. Email: aaronlerner1948@gmail.com

Abstract

SARS-CoV-2, the virus that causes COVID-19, impacts human health all over the world with high morbidity and mortality. Many chronic diseases predispose the patients to be infected, including autoimmune diseases. Despite theoretical and rare exceptions, celiac disease is not a high-risk condition for COVID-19 infection. The present review expends on those potential circumstances that put the CD patients at risk for COVID-19.

Keywords